Process Controllers and Analyzers
Med Vet International Jorvet Plunger Plate for 10cc Hauptner Syringe, J0031D12A
Replacement plunger plate for Jorvet 10cc Hauptner syringe.
Med Vet International Jorvet Metal Cover for 10cc Hauptner Syringe, J0031D14A
Replacement metal cover for Jorvet 10cc Hauptner syringe.
Med Vet International Jorvet Tension Screw for 10cc Hauptner Syringe, J0031D13A
Replacement tension screw for Jorvet 10cc Hauptner syringe.
Med Vet International Jorvet Glass Barrel, for 10cc Henke Roux Syringe, J0053D26B
Replacement Glass Barrel for Jorvet 10cc Henke Roux Syringe.
Med Vet International Jorvet O-Ring for 10cc Syringe, J0111ANO
NY, CT, IL, NJ, NH, DE and MN restrict the sale of syringes and needles to licensed professionals and entities. By proceeding to purchase through our website, you acknowledge that you are over 18 years of age.
Med Vet International Jorvet Rubber Piston, for 10cc Henke Roux Syringe, J0053D30B
Replacement Rubber Piston for Jorvet 10cc Henke Roux Syringe.
Medchemexpress LLC ARS-1323 | 1698024-73-5 | 430.84 | 10 MG
ARS-1323 is a KRAS G12C inhibitor that specifically binds to the cysteine residue on the mutant K-Ras protein, locking it in the GDP-bound conformation. This action blocks K-Ras activation and downstream signaling pathways. It can be used to investigate signal transduction mechanisms and growth characteristics of tumor cells driven by K-Ras G12C.
- Targets Ras
- Inhibits GPCR/G Protein and MAPK/ERK pathway
- Powder storage: -20°C for 3 years, 4°C for 2 years
- In solvent storage: -80°C for 2 years, -20°C for 1 year
- Solubility in DMSO: 100 mg/mL (232.10 mM)
- In vivo solubility options available
Selleck Chemical LLC ARS-853
ARS-853 is a selective covalent KRAS(G12C) inhibitor that inhibits mutant KRAS-driven signaling by binding to the GDP-bound oncoprotein and preventing activation ARS-853 also induces apoptosis
Selleck Chemical LLC ARS-1323-E1856-25MG
ARS-1323 is the racemic mixture containing ARS-1620 and a potent inhibitor of mutant KRAS G12C It can be used in research for biochemical binding screens as companion imaging drugs (CID) for KRAS G12C
Medchemexpress LLC ARS-1323 | 1698024-73-5 | 430.84 | 1 ML
ARS-1323 is a KRAS G12C inhibitor that specifically binds to the cysteine residue on the mutant K-Ras protein. This action locks K-Ras in its GDP-bound conformation, effectively blocking its activation and subsequent downstream signaling pathways. It is utilized for investigating signal transduction mechanisms and the growth characteristics of tumor cells driven by K-Ras G12C.
- Specifically binds to the cysteine residue on mutant K-Ras protein
- Blocks K-Ras activation and downstream signaling pathways
- Used to investigate signal transduction mechanisms
- Used for studying growth characteristics of KRAS G12C-driven tumor cells
- High purity of 99.7%
- Available in solid and solution formulations
Selleck Chemical LLC ARS-853
ARS-853 is a selective covalent KRAS(G12C) inhibitor that inhibits mutant KRAS-driven signaling by binding to the GDP-bound oncoprotein and preventing activation ARS-853 also induces apoptosis